doxorubicin induced cardiomyopathy
Showing 1 - 7 of 7
Cancer, Heart Failure, Arrhythmia Trial in Harbin (Control group:DH001 , Trial group: DH001 low-dose group, Trial group: DH001
Recruiting
- Cancer
- +4 more
- Control group:DH001 placebo
- +2 more
-
Harbin, Heilongjiang, ChinaHarbin Institute of Hematology and Cancer
Oct 20, 2023
Doxorubicin Induced Cardiomyopathy Trial in Cairo (Atorvastatin 40 Mg Oral Tablet, Placebo)
Recruiting
- Doxorubicin Induced Cardiomyopathy
- Atorvastatin 40 Mg Oral Tablet
- Placebo
-
Cairo, EgyptAin Shams University hospitals
Apr 4, 2023
Mitochondrial dysfUnction:Key Player in Doxorubicin-induced
Not yet recruiting
- Doxorubicin Induced Cardiomyopathy
- +3 more
- 31-MRS at 7 Tesla (T)
-
Utrecht, Netherlands
- +1 more
Feb 7, 2023
Breast Cancer, Doxorubicin Induced Cardiomyopathy Trial in Ottawa (99mTc-rhAnnexin V-128)
Terminated
- Breast Cancer
- Doxorubicin Induced Cardiomyopathy
- 99mTc-rhAnnexin V-128
-
Ottawa, Ontario, CanadaUniversity of Ottawa Heart Institute
Nov 17, 2020
Cardiotoxicity, Osteosarcoma, Myocardial Injury Trial in Hangzhou (contrast-enhanced cardiac magnetic resonance imaging(MAGNETOM
Unknown status
- Cardiotoxicity
- +4 more
- contrast-enhanced cardiac magnetic resonance imaging(MAGNETOM Aera 1.5T)
-
Hangzhou, Zhejiang, China2nd Affiliated Hospital, School of Medicine, Zhejiang University
Jul 2, 2020
Doxorubicin Induced Cardiomyopathy, Breast Cancer, Gastric Cancer Trial in Detroit (Exercise)
Completed
- Doxorubicin Induced Cardiomyopathy
- +3 more
- Exercise
-
Detroit, MichiganWilliam Clay Ford Center for Athletic Medicine
Dec 12, 2018
Breast Cancer Female, Doxorubicin Induced Cardiomyopathy Trial in Campinas (Doxorubicin, Achieva, Philips Medical Systems (3T
Completed
- Breast Cancer Female
- Doxorubicin Induced Cardiomyopathy
- Doxorubicin
- +2 more
-
Campinas, São Paulo, BrazilState University of Campinas
Dec 18, 2016